Status:
COMPLETED
Effect of Carbloading and Maltodextrin on the Level of Function in Patients With Apoplexia
Lead Sponsor:
University of Copenhagen
Collaborating Sponsors:
Rigshospitalet, Denmark
Conditions:
Apoplexy; Brain
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
The study will investigate the potential effect of a supplement of maltodextrin and added dietary carbohydrates on the level of function in patients with apoplexia. The study has an intervention group...
Detailed Description
The study will investigate the potential effect of a supplement of maltodextrin (20 g for women and 30 g for men) and added dietary carbohydrates on the level of function in patients with apoplexia. T...
Eligibility Criteria
Inclusion
- Patients with apoplexia who are declared suited for rehabilitation at Afs. Neurologisk Afdeling N 35 - Apopleksi or Afs. Neurologisk Afdeling N 45 - Apopleksi, Rigshospitalet, Glostrup
- Patient must be able to consent participation
- Age 50+ years
- Must be able to understand danish
- Must be relevant for physio- or occupational therapy
Exclusion
- Diabetes Mellitus type I og type II
- Enteral nutrition (tube feeding)
- Barthel-100 over 80 points
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2020
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT04688489
Start Date
August 1 2020
End Date
December 1 2020
Last Update
December 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rigshospitalet, Glostrup
Glostrup, Region Sjælland, Denmark, 2600